AIV
39
6
ILMN
31
4
AAP
26
5
DLTR
52
8
GM
55
6
PRU
39
3
VFC
56
6
USB
50
3
FE
34
4
PSX
24
2
BAC
38
3
PWR
63
3
ITW
45
2
NRG
32
5
AMP
43
2
AMT
30
2
WMB
58
3
PFG
27
7
OXY
42
17
WFC
58
8
AIV
39
6
ILMN
31
4
AAP
26
5
DLTR
52
8
GM
55
6
PRU
39
3
VFC
56
6
USB
50
3
FE
34
4
PSX
24
2
BAC
38
3
PWR
63
3
ITW
45
2
NRG
32
5
AMP
43
2
AMT
30
2
WMB
58
3
PFG
27
7
OXY
42
17
WFC
58
8
Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Sell
33

EYPT
EyePoint Pharmaceuticals

Last Price:
$7.12
Seasonality Move:
7.64%
Sell
22

EDIT
Editas Medicine

Last Price:
$1.33
Seasonality Move:
-11.28%
Sell
33
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $7.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $1.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.64 Sell
Relative Strength Index (14 RSI): 34.11 Sell
Chaikin Money Flow: -639404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.76 - 9.04) Sell
Bollinger Bands (100): (7.84 - 10.36) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 23.89 Sell
Chaikin Money Flow: -1676224 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 2.43) Sell
Bollinger Bands (100): (2.37 - 4.05) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.62 Sell
20-day SMA: 8.29 Sell
50-day SMA: 9.7 Sell
200-day SMA: 11.63 Sell
8-day EMA: 7.61 Sell
20-day EMA: 8.25 Sell
50-day EMA: 8.98 Sell
200-day EMA: 10.9 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.54 Sell
20-day SMA: 1.92 Sell
50-day SMA: 2.6 Sell
200-day SMA: 4.58 Sell
8-day EMA: 1.53 Sell
20-day EMA: 1.88 Sell
50-day EMA: 2.47 Sell
200-day EMA: 4.44 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):